Workflow
Prairie Provident Announces Completion of Preferred Share Financing and Debt Amendments
Globenewswire· 2025-11-03 22:00
CALGARY, Alberta, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. ("Prairie Provident" or the "Company") (TSX:PPR) is pleased to announce completion of its previously-announced preferred share financing (the "Equity Financing"), raising C$26.5 million of additional equity capital, and concluded amendments to its debt agreements to extend maturities by 24 months, defer cash interest obligations through 2026, and adjust financial covenants (the "Debt Amendments"). Equity Financing The Equit ...
Beam Therapeutics to Present Updated Data from BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting
Globenewswire· 2025-11-03 22:00
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy data from the BEACON Phase 1/2 clinical trial of BEAM-101 in sickle cell disease (SCD) at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 6-9, 2025, in Orlando. BEAM-101 is an investigational genetically modifie ...
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
Globenewswire· 2025-11-03 22:00
Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology™ platformEVX-04 is a therapeutic cancer vaccine candidate designed for acute myeloid leukemiaNew data showing EVX-04 induces strong T-cell responses and cancer cell killing will be presented at an oral session at the American Society of Hematology (ASH) Annual Meeting and Exposition in Florida on December 6, 2025The concept behind EVX-04 is broadly applicable with pot ...
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
Globenewswire· 2025-11-03 22:00
SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in oncology and autoimmune disease, today announced that updated clinical data from the NX-5948-301 Phase 1a/1b clinical trial have been selected for presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 6 – 9, 2025, ...
Oxbridge / SurancePlus Provide Performance Update on 2025/26 Tokenized Reinsurance Offerings
Globenewswire· 2025-11-03 22:00
GRAND CAYMAN, Cayman Islands, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary SurancePlus, today announced an update on the performance of its 2025/2026 tokenized reinsurance securities. EtaCat Re – Balanced Yield Token: Targeted 20% - Tracking 25%ZetaCat Re – High Yield Token: Targeted 42% - Is on track to achieve its targeted return Jay Madhu, CE ...
Aptose Tuspetinib Clinical Data from Ongoing TUSCANY Trial in Newly Diagnosed AML Selected for Presentation at the 2025 ASH Annual Meeting
Globenewswire· 2025-11-03 22:00
Abstract available on ASH websiteSAN DIEGO and TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat patients with newly diagnosed acute myeloid leukemia (AML), today announced that an abstract from its TUSCANY study of tuspetinib with standard of care venetoclax and azacitidine in patients with newly diagnosed AML has been selected for p ...
Stride, Inc. Authorizes $500 Million Stock Repurchase Program
Globenewswire· 2025-11-03 22:00
RESTON, Va., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Stride, Inc. (NYSE: LRN) (“Stride,” the “Company,” “we,” or “our”), one of the nation’s most successful technology-based education companies, today announced the approval of a stock repurchase program that authorizes the repurchase of up to $500 million of shares of Stride’s common stock until October 31, 2026. “Stride’s Board of Directors and management team remain confident in the Company’s long-term outlook and believes in the investments we are making to up ...
SalMar - Invitation to presentation of the third quarter 2025 results
Globenewswire· 2025-11-03 22:00
SalMar presents results for the third quarter 2025 on Thursday 6 November 2025 at 08:00 CET. The presentation will be held at Grand Hotel in Oslo. Please note that the presentation will be held at Grand Hotel in Oslo, Karl Johans gate 31, and not at Hotel Continental as in previous quarterly presentations. CEO Frode Arntsen and CFO Ulrik Steinvik will be representing the company. The presentation will in addition be available on Norwegian webcast at 08:00 CET on www.salmar.no. There will be opportunity to s ...
Scripps Howard Fund invests record-breaking $1.8 million to provide books for children at low-income schools
Globenewswire· 2025-11-03 22:00
"If You Give a Child a Book ..." campaign Donate at IfYouGiveABook.com. CINCINNATI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Scripps Howard Fund’s ninth annual “If You Give a Child a Book …” campaign will invest a record-breaking $1.8 million during the 2025-2026 academic year, which will provide more than 300,000 books to children at low-income schools across the United States. The childhood literacy campaign is supported by The E.W. Scripps Company (NASDAQ: SSP) and the communities it serves, Scripps emp ...
Gevo Makes First Delivery of Certified Carbon Credits to Biorecro, Unlocking Value from Carbon as a Co-Product
Globenewswire· 2025-11-03 22:00
Gevo expands its carbon business with the groundbreaking delivery, adding a new stream of repeatable revenue now including carbon removal credits (CORCs) in addition to ethanol, protein, vegetable oil, and tax credit salesENGLEWOOD, Colo., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) announced the production and delivery of certified carbon dioxide removal credits, known as CORCs under the high-integrity Puro.earth standard, to Biorecro North America, LLC, marking a major milestone in the com ...